Cargando…
Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?
Coronavirus disease 2019 (COVID-19) is now at the forefront of major health challenge faced globally, creating an urgent need for safe and efficient therapeutic strategies. Given the high attrition rates, high costs, and quite slow development of drug discovery, repurposing of known FDA-approved mol...
Autores principales: | Devaux, Christian A., Melenotte, Cléa, Piercecchi-Marti, Marie-Dominique, Delteil, Clémence, Raoult, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450353/ https://www.ncbi.nlm.nih.gov/pubmed/34552938 http://dx.doi.org/10.3389/fmed.2021.663708 |
Ejemplares similares
-
Pro-apoptotic effect of doxycycline and hydroxychloroquine on B-cell lymphoma induced by C. burnetii
por: Melenotte, Cléa, et al.
Publicado: (2017) -
Could β-Lactam Antibiotics Block Humoral Immunity?
por: Melenotte, Cléa, et al.
Publicado: (2021) -
Blood Culture–Negative Cardiovascular Infection in a Patient With Multiple Sclerosis
por: Melenotte, Cléa, et al.
Publicado: (2019) -
High Concentrations of Serum Soluble E-Cadherin in Patients With Q Fever
por: Mezouar, Soraya, et al.
Publicado: (2019) -
Sexual Dimorphism and Gender in Infectious Diseases
por: Gay, Laetitia, et al.
Publicado: (2021)